EcoR1 Capital

Summary

EcoR1 Capital appeared to be the VC, which was created in 2012. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the San Francisco.

We also calculated 2 valuable employees in our database.

The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the EcoR1 Capital, startups are often financed by ARCH Venture Partners, Third Rock Ventures, The Column Group. The meaningful sponsors for the fund in investment in the same round are Fidelity Management and Research Company, Cormorant Asset Management, Samsara BioCapital. In the next rounds fund is usually obtained by Polaris Partners, Fidelity Management and Research Company, Cormorant Asset Management.

Among the most popular portfolio startups of the fund, we may highlight Clementia Pharmaceuticals, Relay Therapeutics, Codiak Biosciences. Among the most popular fund investment industries, there are Genetics, Medical Device. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.

The increased amount of exits for fund were in 2018. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 15 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 50 - 100 millions dollars are the general things for fund. This EcoR1 Capital works on 22 percentage points more the average amount of lead investments comparing to the other organizations.